Anti-CD74 (clone hLL1)-SMCC-Dox ADC

  • 1.00 Dollar US$
  • Published date: November 16, 2017
    • New York, New York, United States

This ADC product is comprised of an anti-CD74 monoclonal antibody (clone hLL1) conjugated via a SMCC linker to DOX. The DOX is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DOX binds to DNA, causes DNA damage.

Disulfide Linkers, are extensively exploited as a chemically labile linkage. Since the release of disulfide-linked drugs requires a cytoplasmic thiol cofactor, such as glutathione (GSH). Disulfides maintain stable at physiological pH and only when ADCs are internalized inside cells, the cytosol provides reducing environment including intracellular enzyme protein disulfide isomerase, or similar enzymes, drugs can be released.

Doxorubicin is the generic name for the trade name drug, Adriamycin®, as well as, Rubex®, which is a type of anti-cancer chemotherapy drug called an anthracycline. Doxorubicin works by blocking an enzyme called TopoisomeraseⅡthat cancer cells need to divide and grow.

Result 0 votes
Jerry Carter
1 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • 5-Bromoindole

    5-Bromoindole

    Drug Development Shirley (New York) February 13, 2020 Check with publisher

    5-Bromoindole is a GSK-3 inhibitor. https://www.bocsci.com/5-bromoindole-cas-10075-50-0-item-158606.html

  • FM19G11

    FM19G11

    Drug Development Shirley (New York) February 13, 2020 Check with publisher

    FM19G11 is a hypoxia inducible factors α (HIFα) inhibitor. It has been reported to inhibit transcriptional activity of pluripotency markers (Sox2 and Oct4) in rodent and human stem cells under hypoxic conditions. https://www.bocsci.com/fm19g11-cas-32...

  • D-3

    D-3

    Drug Development Shirley (New York) February 13, 2020 Check with publisher

    D-3 is a peptide exhibits toxicity in cultured iPSCs and ESCs after 1h of incubation. https://www.bocsci.com/d-3-cas-1967815-98-0-item-286100.html